Publications

Publications

 

Sorted by date

 

  • Safety and Immunogenicity of TG4050; a personalized cancer vaccine in head and neck carcinoma
    C Ottensmeier, et al. ASCO 2023 Abstract available on the ASCO website – Download the abstract here Poster Presentation
  • Immunogenicity and clinical activity of Tipapkinogen sovacivec (TG4001), an HPV-16 cancer vaccine: a randomized phase 2 study in recurrent or metastatic (R/M)  anogenital cancers

    C. Le Tourneau, et al.
    ASCO 2023
    Abstract available on the ASCO website – Download the abstract here
    Poster Presentation

  • Advanced patient-derived lung tumoroids to identify limiting factors for oncolytic virotherapy

    H. Le et al.
    AACR 2023
    Download the poster here
    Poster Presentation

  • PoxSTG, a novel chimeric poxvirus with improved oncolytic potency

    P Erbs et al.
    AACR 2023
    Download the poster here
    Poster Presentation

  • Oncolytic virus TG6002 safety and activity after intrahepatic artery administration in patients with liver-dominant metastatic colorectal cancer

    A. Samson et al.
    AACR 2023
    Download the poster here
    Poster Presentation

  • Feasibility and immunogenicity of adjuvant TG4050, a patient tailored cancer vaccine in head and neck and ovarian cancer

    A. Lalane et al.
    AACR 2023
    Download the poster here
    Poster Presentation

  • A randomized phase II trial of TG4001 plus avelumab versus avelumab alone in recurrent/metastatic (R/M) human papilloma virus (HPV)-16 positive anogenital cancers

    C. Le Tourneau et al.
    AACR 2023
    Download the poster here
    Poster Presentation

  • Selection of an optimal anti-PD-L1 single domain antibody format for the vectorization into oncolytic vaccinia virus and the generation of bispecific immunomodulators

    JB. Marchand et al.
    AACR 2023
    Download the poster here
    Poster Presentation

  • TG6050 an oncolytic vaccinia virus armed with interleukin 12 and anti-CTLA4 antibody induces TME remodeling and strong anti-tumoral responses

    JB. Marchand et al.
    AACR 2023
    Download the poster here
    Poster Presentation

  • Extracellular vesicles (EV): mediators of therapeutic vaccination? In vivo and in vitro characterization of EVs generated after infection of human and murine cells with therapeutic poxviruses

    L. Walther et al.
    AACR 2023
    Download the poster here
    Poster Presentation

  • Safety and Immunogenicity of TG4050; a personalized cancer vaccine in head and neck carcinoma

    C Ottensmeier, et al.
    ASCO 2023
    Abstract available on the ASCO website – Download the abstract here
    Poster Presentation

  • Immunogenicity and clinical activity of Tipapkinogen sovacivec (TG4001), an HPV-16 cancer vaccine: a randomized phase 2 study in recurrent or metastatic (R/M)  anogenital cancers

    C. Le Tourneau, et al.
    ASCO 2023
    Abstract available on the ASCO website – Download the abstract here
    Poster Presentation

  • Advanced patient-derived lung tumoroids to identify limiting factors for oncolytic virotherapy

    H. Le et al.
    AACR 2023
    Download the poster here
    Poster Presentation

  • PoxSTG, a novel chimeric poxvirus with improved oncolytic potency

    P Erbs et al.
    AACR 2023
    Download the poster here
    Poster Presentation

  • Oncolytic virus TG6002 safety and activity after intrahepatic artery administration in patients with liver-dominant metastatic colorectal cancer

    A. Samson et al.
    AACR 2023
    Download the poster here
    Poster Presentation

  • Feasibility and immunogenicity of adjuvant TG4050, a patient tailored cancer vaccine in head and neck and ovarian cancer

    A. Lalane et al.
    AACR 2023
    Download the poster here
    Poster Presentation

  • A randomized phase II trial of TG4001 plus avelumab versus avelumab alone in recurrent/metastatic (R/M) human papilloma virus (HPV)-16 positive anogenital cancers

    C. Le Tourneau et al.
    AACR 2023
    Download the poster here
    Poster Presentation

  • Selection of an optimal anti-PD-L1 single domain antibody format for the vectorization into oncolytic vaccinia virus and the generation of bispecific immunomodulators

    JB. Marchand et al.
    AACR 2023
    Download the poster here
    Poster Presentation

  • TG6050 an oncolytic vaccinia virus armed with interleukin 12 and anti-CTLA4 antibody induces TME remodeling and strong anti-tumoral responses

    JB. Marchand et al.
    AACR 2023
    Download the poster here
    Poster Presentation

  • Extracellular vesicles (EV): mediators of therapeutic vaccination? In vivo and in vitro characterization of EVs generated after infection of human and murine cells with therapeutic poxviruses

    L. Walther et al.
    AACR 2023
    Download the poster here
    Poster Presentation

 

Sorted by product

 

  • TG6050 an oncolytic vaccinia virus armed with interleukin 12 and anti-CTLA4 antibody induces TME remodeling and strong anti-tumoral responses

    JB. Marchand et al.
    AACR 2023
    Download the poster here
    Poster Presentation